A(4-24)(F23A)H2 [417]



A(4-24)(F23A)H2


SMILES CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
InChIKey JPICFXXNKSFHNE-FHWINVSDSA-N
Sequence SALANKCCHVGCTKRSLARAC
HELM PEPTIDE1{S.A.L.A.N.K.C.C.H.V.G.C.T.K.R.S.L.A.R.A.C}$$$$

Chemical Properties

Hydrogen bond acceptors 35
Hydrogen bond donors 37
Rotatable bonds 73
Log P -14.156
Molecular weight (Da) 2191.1
Stereochemistry info partial

Database connections



No bioactivity data available.

A(4-24)(F23A)H2


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.